Publication: Behcet's disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms
No Thumbnail Available
Date
1997
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
SPRINGER VERLAG
Abstract
Two patients with chronic myelogenous leukemia (CML) who developed characteristic features of Behcet's disease (ED) during alpha-interferon (IFN-alpha) treatment and another patient who had a diagnosis of ED preceding CML are presented. In the first two patients, features of ED appeared 6 months after the initiation of IFN-alpha treatment; they included recurrent oral aphthae, genital ulceration, arthritis, folliculitis, and a positive skin pathergy test. The third patient, however, had a diagnosis of Behcet's disease 4 years before diagnosis of Philadelphia-positive CML. We prospectively examined the skin pathergy reaction in a group of patients with CML, multiple myeloma, and hairy cell leukemia both before and after IFN-alpha treatment and found two additional patients with CML who developed a positive skin pathergy test following IFN-alpha treatment.
Description
Keywords
Behcet's disease, chronic myelogenous leukemia, pathergy reaction, adverse effect, alpha-interferon, CHRONIC MYELOID-LEUKEMIA, PROGENITOR CELLS, THERAPY